AIM: To evaluate the treatment plans of 3D image-guided brachytherapy (BT) and stereotactic robotic radiotherapy with online image guidance - CyberKnife (CK) in patients with locally advanced cervix cancer. METHODS AND MATERIALS: Ten pairs of plans for patients with locally advanced inoperable cervical cancer were created using MR based 3D brachytherapy and stereotaxis CK. The dose that covers 98% of the target volume (HR CTV D98) was taken as a reference and other parameters were compared. RESULTS: Of the ten studied cases, the dose from D100 GTV was comparable for both devices, on average, the BT GTV D90 was 10-20% higher than for CK. The HR CTV D90 was higher for CK with an average difference of 10-20%, but only fifteen percent of HR CTV (the peripheral part) received a higher dose from CK, while 85% of the target volume received higher doses from BT. We found a significant organ-sparing effect of CK compared to brachytherapy (20-30% lower doses in 0.1 cm(3), 1 cm(3), and 2 cm(3)). CONCLUSION: BT remains to be the best method for dose escalation. Due to the significant organ-sparing effect of CK, patients that are not candidates for BT could benefit from stereotaxis more than from classical external beam radiotherapy.

Department of Gynecology University Hospital Ostrava Ostrava Czech Republic

Department of Oncology University Hospital Ostrava Ostrava Czech Republic

Oncology Centre Multiscan and Pardubice Regional Hospital Pardubice Czech Republic

Zobrazit více v PubMed

Viswanathan A.N., Thomadsen B. American Brachytherapy Society Cervical Cancer Recommendations Committee American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy. 2012;11(1):33–46. PubMed

Marnitz S., Stromberger C., Kawgan-Kagan M. Helical tomotherapy in cervical cancer patients: simultaneous integrated boost concept: technique and acute toxicity. Strahlenther Onkol. 2010;186:572–579. PubMed

Paton A.M., Chalmers K.E., Coomber H., Cameron A.L. Dose escalation in brachytherapy for cervical cancer: impact on (or increased need for) MRI-guided plan optimisation. Br J Radiol. 2012;85:1249–1255. PubMed PMC

Pötter R., Haie-Meder C., Van Limbergen E. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78(1):67–77. PubMed

Toossi M.T.B., Ghorbani M., Makhdoumi Y. A retrospective analysis of rectal and bladder dose for gynecological brachytherapy treatments with GZP6 HDR afterloading system. Rep Pract Oncol Radiother. 2012;17(6):352–357. PubMed PMC

Guedea F. Recent developments in brachytherapy. Rep Pract Oncol Radiother. 2011;16(6):203–206. PubMed PMC

Dimopoulos J., Lang S., Kirisits C. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys. 2009;75:56–63. PubMed

Guckenberger M., Bachmann J., Wulf J. Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer. Radiother Oncol. 2010;94(January (1)):53–59. PubMed

Krempien R.C., Daueber S., Hensley F.W. Image fusion of CT and MRI data enables improved target volume definition in 3D-brachytherapy treatment planning. Brachytherapy. 2003;2(3):164–171. PubMed

Dieterich S., Gibbs I.C. The CyberKnife in clinical use: current roles, future expectations. Front Radiat Ther Oncol. 2011;43:181–194. PubMed

Antypas C., Pantelis E. Performance evaluation of a CyberKnife G4 image-guided robotic stereotactic radiosurgery system. Phys Med Biol. 2008;53(17):4697–4718. PubMed

Dolezel M., Odrazka K., Vanasek J. MRI-based pre-planning in patients with cervical cancer treated with three-dimensional brachytherapy. Br J Radiol. 2011;84(1005):850–856. PubMed PMC

Cengiz M., Dogan A., Ozyigit G. Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer. Brachytherapy. 2012;11(2):125–129. PubMed

Georg D., Kirisits C., Hillbrand M. Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys. 2008;71(4):1272–1278. PubMed

Lee J.E., Han Y., Huh S.J. Interfractional variation of uterine position during radical RT: weekly CT evaluation. Gynecol Oncol. 2007;104(1):145–151. PubMed

Buchali A., Koswig S., Dinges S. Impact of the filling status of the bladder and rectum on their integral dose distribution and the movement of the uterus in the treatment planning of gynaecological cancer. Radiother Oncol. 1999;52(1):29–34. PubMed

Kaatee R.S., Olofsen M.J., Verstraate M.B. Detection of organ movement in cervix cancer patients using a fluoroscopic electronic portal imaging device and radiopaque markers. Int J Radiat Oncol Biol Phys. 2002;54(2):576–583. PubMed

Fuller D.B., Lee C., Hardy S. Virtual HDRsm CyberKnife prostate treatment: toward the development of non-invasive HDR dosimetry delivery and early clinical observations. Int J Radiat Oncol Biol Phys. 2008;70(5):588–1597. PubMed

Tanderup K., Nesvacil N., Pötter R., Kirisits C. Uncertainties in image guided adaptive cervix cancer brachytherapy: impact on planning and prescription. Radiother Oncol. 2013;107/1(1–5) 0167-8140. PubMed

Landoni F., Maneo A., Colombo A. Randomised study of radical surgery versus radiotherapy for stage Ib–IIa cervical cancer. Lancet. 1997;350:535–540. PubMed